Fortrea Holdings Inc.
- Indústria
- Pharma Outsourcing (CRO)
- Bolsa
- EUA
- País / Região
- USA
- Data do IPO
- 3 de julho de 2023
- Funcionários
- 14.000
- Site
- www.fortrea.com
Faixa de valuation composta · conservador $8–$10 / justo $15–$19 / otimista $24–$28. A $15.31, Dentro da faixa de valor intrínseco justo.
Na publicação $16.87 (12 de junho de 2026)
Ainda não há análises sobre este ativo no seu idioma.
Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical pharmacology, such as clinical research units, external partnerships, project management, study design and monitoring, bioanalytics and biomarkers, pharmacokinetics, modeling and simulation, and biometrics; and clinical development, including phase I through IV clinical and real-world evidence studies, regulatory affairs, protocol design, operational planning, study and site start-up, patient recruitment, project management, comprehensive site and medical monitoring, data management and biostatistics, pharmacovigilance, medical writing, and mobile clinical services. The company also provides consulting services comprising product development and regulatory, market access and health economics, and outcomes research, as well as RWE services. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.
Dados da EODHD, apresentados na moeda de reporte; apenas para referência, não constitui recomendação de investimento.
História
Em breveEsta seção está sendo preenchida — volte em breve.
Posição no setor
Em breveEsta seção está sendo preenchida — volte em breve.